openPR Logo
Press release

John Hosier Joins Fight Cancer Global's Scientific Advisory Board

09-01-2023 08:46 AM CET | Health & Medicine

Press release from: John Hosier Healthcare Consulting, LLC

John Hosier, President, John Hosier Healthcare Consulting & Parallax Life Sciences Consulting

John Hosier, President, John Hosier Healthcare Consulting & Parallax Life Sciences Consulting

Fight Cancer Global, a leading non-profit organization dedicated to advancing cancer research, treatment, and patient support, is pleased to announce the addition of John Hosier to its esteemed Scientific Advisory Board. A renowned expert in healthcare consulting, Mr. Hosier brings a wealth of knowledge and experience to the organization's mission of tackling cancer on a global scale.
John Hosier is the founder and President of John Hosier Healthcare Consulting and Parallax Life Sciences Consulting, both known for thier innovative approaches to operational design and marketing strategy. With over two decades of experience in the healthcare industry, and oncology/hematology product marketing and commercial development specifically, Mr. Hosier has demonstrated a keen ability to navigate complex challenges and identify strategic opportunities for his clients. His expertise in sales, marketing, managed markets, organizational design, and patient-centered care solutions has earned him recognition as a thought leader in the field.

"We are thrilled to welcome John Hosier to Fight Cancer Global's Scientific Advisory Board," said Dr. Rohit Irvine, Chair of the Advisory Board. "His unique perspective and extensive experience in healthcare consulting will undoubtedly enhance our efforts to drive forward advancements in cancer research and patient care. We look forward to benefiting from his insights as we continue our mission to fight cancer globally."

As a member of the Scientific Advisory Board, Mr. Hosier will play a pivotal role in shaping the organization's strategic direction, offering guidance on research initiatives, patient care programs, and collaborations with leading medical institutions around the world. "His dedication to improving healthcare outcomes aligns seamlessly with Fight Cancer Global's commitment to making a lasting impact in the lives of those affected by cancer." Added Vijay Kondur, FCG's global CEO.

"I am honored to join Fight Cancer Global's Scientific Advisory Board," said John Hosier. "Cancer poses one of the most significant challenges to global health, and I am excited to contribute my expertise to an organization that is actively working to address this issue head-on. Leveraging innovation, experience, and collaboration, we can make meaningful strides in clinical trial and biobank infrastructure in less developed nations."

John Hosier's addition to Fight Cancer Global's Scientific Advisory Board marks a significant step in the organization's ongoing efforts to assemble a diverse group of experts and leaders who are passionate about driving change in the field of cancer research and care.

For Media Inquiries:
17 Avenue At Port Imperial, 947
West New York, NJ, 07093

About Fight Cancer Global:
Fight Cancer Global is a non-profit organization dedicated to advancing cancer research, treatment, and patient support on a global scale. With a focus on collaboration, innovation, and patient-centered care, Fight Cancer Global aims to make meaningful contributions to the fight against cancer. The organization's Scientific Advisory Board comprises leading experts and thought leaders who guide its strategic initiatives and ensure the highest level of scientific rigor.

About John Hosier:
Mr. Hosier is a strategic advisor to the life sciences industry, where he has maintained a heavy concentration in oncology and rare disease. Before launching his both of his consulting firms, Mr. Hosier held leadership positions of increasing responsibility including sales, marketing, account management, state & federal policy, pricing/contracting, and commercial operations for numerous organizations including: Zeneca, Pharmacia & Upjohn, Pfizer, Roche, and Eisai.
Websites: |

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release John Hosier Joins Fight Cancer Global's Scientific Advisory Board here

News-ID: 3191188 • Views: 280

More Releases from John Hosier Healthcare Consulting, LLC

John Hosier Healthcare Consulting Expands with JHHC Creative
John Hosier Healthcare Consulting Expands with JHHC Creative
John Hosier Healthcare Consulting (JHHC) takes a creative leap with the launch of JHHC Creative, a dedicated creative services team aimed at delivering innovative solutions for pharmaceutical and biotech companies. This move expands their offerings to meet the dynamic needs of their clients. John Hosier, Founder, and CEO of JHHC, expressed the company's rationale for this expansion, stating, "This is a natural evolution for us, as more and more of our

More Releases for Cancer

Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose. Increase in incidence of target diseases like cancer is key driving factor which is expected to boost
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business. Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine. These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports. This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top